by sequential ultrasonographic examinations during fetal life and following birth. Spontaneous closure of the VSD, need for intervention, additional abnormalities and chromosomal aberrations were collected and analysed. Results: From the original cohort of 86 isolated VSDs 11 cases (12.7%) were later excluded because of lost to follow up, termination of pregnancy and diagnosis of an extra-cardiac structural malformation before delivery. Seventy-five cases of isolated VSDs with complete data on outcome further analysed. Muscular VSDs found in 64 fetuses (85.3%) and perimembraneous VSDs in 11 fetuses (14.6%). Spontaneous closure of the VSD occurred in 59 (92.2%) cases with muscular VSDs, and in five (45.5%) cases with perimembraneous VSDs. Postnatal treatment was indicated in three (27.3%) patients with a perimembraneous defect and in none of the patients with a muscular defect. Only one child (9.1%) with a perimembraneous defect had a chromosomal anomaly detected. Conclusions: Isolated muscular VSDs usually close spontaneously during pregnancy or in the first two years of life and do not increase the risk for chromosomal aberrations. These cases have a good prognosis and probably need no further prenatal work-up. On the other hand, isolated perimembraneous VSDs may be associated with chromosomal anomalies and may need intervention following birth and further genetic prenatal investigation. Objectives: To assess the association between ARSA and Trisomy 21. Methods: We enrolled 7557 consecutive low-risk pregnant women who had prenatal anatomy survey during the last 5 years at 14-16 weeks' gestation by a single operator. Heart assessment included four-chamber view, inlet and outflow tracts, 3-vessel view, superior and inferior vena cava and pulmonary veins. For diagnosis of ARSA three vessels and trachea view was obtained and colour Doppler with a low-velocity range power Angio was applied, demonstrating its anomalous origin on the aortic arch and its retro-tracheal course toward the right shoulder. When ARSA was detected, longitudinal view was obtained to confirm the diagnosis. All cases of ARSA were approved by second trimester fetal echography and had amniocentesis for karyotype or for chromosomal microarray analysis (CMA). Results: We identified 27 fetuses with ARSA (27/7557 0.35%) that was considered to be isolated. Following delivery, in 3 cases other associated abnormalities were diagnosed including soft cleft palate, patent foramen ovale and abnormal CMA (was done on a SNP array (GXG_ComprehensiveArray_V1, Illumina)) that showed a 54,369KB duplication on chromosome 18 (arr 18q11.2q23(23,708,113-78,077,248)X3). This duplication encompasses most of the long arm of chromosome 18. No Trisomy 21 cases were diagnosed in the fetuses with ARSA. Twenty-four cases of Trisomy 21 were diagnosed in the study population; none of those cases had ARSA. Conclusions: Isolated ARSA is not associated with Down syndrome. Detection of ARSA should be followed by fetal echocardiography and comprehensive anatomy scan. Although our series is too small to established firm recommendation on this regard, we believe that CMA and karyotype should be considered. 
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Objectives: Our aim is to investigate the application value and clinical significance of echocardiography in the diagnosis of fetal ventricular septal defect (VSD) and the follow-up of postnatal outcomes. Methods: 30,359 cases of pregnant women with single fetus in 24-32 week gestation were screened with fetal echocardiography from January 2014 to December 2016 in our hospital. We retrospectively analysed the detection rate, the size and the type of pure VSD in fetal echocardiography. Additionally, 86 cases with pure VSD underwent echocardiography at 6 months after birth, and we assessed the possibility of recovery retrospectively. Results: 438 cases in all fetuses were diagnosed with VSD and the detection rate was 1.44%, of which 146 cases had other malformations and 292 cases had pure VSD with a detection rate of 0.96%, including 138 cases with muscular VSD (47.3%), 144 cases with perimembraneous VSD (49.3%) and 10 cases with infundibular VSD (3.4%). There were 86 cases with follow-up records, including 38 cases with muscular VSD, 45 cases with perimembraneous VSD and 3 cases with infundibular VSD. All of them underwent echocardiography at 6 months, and 35 of 86 cases (40.7%) had no VSD, including 24 cases and 11 cases previously diagnosed respectively with muscular and perimembraneous VSD. The above cases had an average diameter of defect regions with (2.22 + 0.33) mm, and all diameters were less than 3 mm in fetal echocardiography. However, 3 cases with infundibular VSD still existed. Conclusions: Echocardiography has a high detection rate of fetal muscular and perimembraneous VSD in the second and third trimester. Muscular or perimembraneous VSD with the maximum diameter at no more than 3 mm has good prognosis, and it is necessary to follow up these cases with echocardiography closely. Therefore, echocardiography plays an important role in the diagnosis and postpartum outcome of fetal VSD.
